Cape Verde vs Indonesia: Hepatitis B surface antigen (HBsAg) prevalence
Cape Verde
0.7%
in 2024
Indonesia
0.7%
in 2024
Cape Verde rank
43rd
Indonesia rank
43rd
Hepatitis B surface antigen (HBsAg) prevalence over time
- Cape Verde
- Indonesia
How they compare
Cape Verde currently reports 0.7% against 0.7% in Indonesia, a difference of 0.0%.
The two have swapped places 2 times across 10 shared years of data; in 2015 it was Indonesia ahead.
Cape Verde ranks 43rd and Indonesia ranks 43rd of 194 countries.
Indonesia has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Cape Verde | Indonesia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.8% | 0.9% | 0.1% | Indonesia |
| 2020s | 0.6% | 0.8% | 0.2% | Indonesia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hepatitis b surface antigen (hbsag) prevalence, Cape Verde or Indonesia?
- Cape Verde, at 0.7% against 0.7% in Indonesia as of 2024.
- What is the difference in hepatitis b surface antigen (hbsag) prevalence between Cape Verde and Indonesia?
- 0.0%, with Cape Verde ahead.
- How many years of comparable data are there for Cape Verde and Indonesia?
- 10 years are reported by both, from 2015 to 2024.
- How do Cape Verde and Indonesia rank globally for hepatitis b surface antigen (hbsag) prevalence?
- Cape Verde ranks 43rd and Indonesia ranks 43rd of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Hepatitis B surface antigen (HBsAg) prevalence (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.